PCVX Annual Total Liabilities
$167.45 M
+$114.88 M+218.56%
31 December 2023
Summary:
As of January 22, 2025, PCVX annual total liabilities is $167.45 million, with the most recent change of +$114.88 million (+218.56%) on December 31, 2023. During the last 3 years, it has risen by +$120.47 million (+256.40%). PCVX annual total liabilities is now -2.69% below its all-time high of $172.07 million, reached on December 31, 2019.PCVX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Quarterly Total Liabilities
$142.11 M
+$40.98 M+40.52%
30 September 2024
Summary:
As of January 22, 2025, PCVX quarterly total liabilities is $142.11 million, with the most recent change of +$40.98 million (+40.52%) on September 30, 2024. Over the past year, it has increased by +$48.77 million (+52.25%). PCVX quarterly total liabilities is now -17.41% below its all-time high of $172.07 million, reached on December 31, 2019.PCVX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +218.6% | +52.3% |
| 3 y3 years | +256.4% | +195.4% |
| 5 y5 years | +30.3% | - |
PCVX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +315.3% | -15.1% | +252.5% |
| 5 y | 5-year | -2.7% | +315.3% | -17.4% | +475.7% |
| alltime | all time | -2.7% | +315.3% | -17.4% | +475.7% |
Vaxcyte Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $142.11 M(+40.5%) |
| June 2024 | - | $101.14 M(-5.8%) |
| Mar 2024 | - | $107.32 M(-35.9%) |
| Dec 2023 | $167.45 M(+218.6%) | $167.45 M(+79.4%) |
| Sept 2023 | - | $93.34 M(+34.4%) |
| June 2023 | - | $69.44 M(+9.5%) |
| Mar 2023 | - | $63.39 M(+20.6%) |
| Dec 2022 | $52.56 M | $52.56 M(-0.4%) |
| Sept 2022 | - | $52.75 M(+16.9%) |
| June 2022 | - | $45.12 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $43.17 M(+7.1%) |
| Dec 2021 | $40.32 M(-14.2%) | $40.32 M(-16.2%) |
| Sept 2021 | - | $48.11 M(+17.3%) |
| June 2021 | - | $41.03 M(-26.0%) |
| Mar 2021 | - | $55.41 M(+17.9%) |
| Dec 2020 | $46.98 M(-72.7%) | $46.98 M(+18.2%) |
| Sept 2020 | - | $39.74 M(+20.3%) |
| June 2020 | - | $33.04 M(+33.8%) |
| Mar 2020 | - | $24.68 M(-85.7%) |
| Dec 2019 | $172.07 M(+33.9%) | $172.07 M |
| Dec 2018 | $128.53 M | - |
FAQ
- What is Vaxcyte annual total liabilities?
- What is the all time high annual total liabilities for Vaxcyte?
- What is Vaxcyte annual total liabilities year-on-year change?
- What is Vaxcyte quarterly total liabilities?
- What is the all time high quarterly total liabilities for Vaxcyte?
- What is Vaxcyte quarterly total liabilities year-on-year change?
What is Vaxcyte annual total liabilities?
The current annual total liabilities of PCVX is $167.45 M
What is the all time high annual total liabilities for Vaxcyte?
Vaxcyte all-time high annual total liabilities is $172.07 M
What is Vaxcyte annual total liabilities year-on-year change?
Over the past year, PCVX annual total liabilities has changed by +$114.88 M (+218.56%)
What is Vaxcyte quarterly total liabilities?
The current quarterly total liabilities of PCVX is $142.11 M
What is the all time high quarterly total liabilities for Vaxcyte?
Vaxcyte all-time high quarterly total liabilities is $172.07 M
What is Vaxcyte quarterly total liabilities year-on-year change?
Over the past year, PCVX quarterly total liabilities has changed by +$48.77 M (+52.25%)